American Assets Trust enters the back half of August defined by one thing: its Executive Chairman is buying the dip aggressively, even as the stock trades 11% below last month's levels.
Ernest Rady has purchased roughly 379,000 shares across six transactions since August 5, spending approximately $7.8 million in the process. The cluster runs from $22.45 to $23.04 per share — all below the current close of $22.60. His institutional position now stands at 14.4% of the company, built through a pattern of consistent open-market accumulation that also included two $10,000-share purchases in June at prices above $24. Net insider buying over the past 90 days totals nearly 695,000 shares, worth just over $15.6 million. For a REIT of AAT's size, that level of conviction from the company's founder and largest individual holder is hard to ignore.
Positioning in the lending market offers no countervailing short pressure. Short interest is only 1.9% of the free float — and falling fast, down 21% on the week and 19% on the month. Borrow costs run at just 0.52%, a fraction of their early-July levels. Availability is extraordinarily loose at over 3,280% — meaning roughly 33 shares sit in the lending pool for every one currently borrowed. The ORTEX short score has drifted lower to 32.9, down from 35.8 earlier in the month, reflecting this retreat in short activity. Options traders are equally unconcerned about downside: the put/call ratio is running at 0.13, just marginally above its 20-day average, placing it near the low end of its 52-week range. Nothing in the positioning data suggests any meaningful short thesis is building here.
The Street is more guarded than the Chairman. Morgan Stanley maintains an Underweight rating on the stock despite raising its target to $24 from $18 on July 22 — a sharp target lift that nonetheless kept the bearish label in place. The mean analyst price target is $23.50, implying modest upside from current levels. Valuation multiples have moved in mixed directions over the past month: the EV/EBITDA multiple has crept higher, while the trailing P/E has compressed, reflecting the 11% monthly price decline running ahead of any earnings revision. Factor scores are unremarkable across the board — a 49th-percentile analyst recommendation differential, a 41st-percentile dividend score, and a 59th-percentile short score rank. The stock scores as mid-table rather than a standout in any direction.
Earnings history adds a cautionary note. The two most recent quarterly reports both triggered immediate declines — a 2.5% drop the day after Q2 results in late July, extending to a 4.8% loss over the following five days. That pattern holds even as Rady bought aggressively in the days surrounding the print. The next report is scheduled for October 27.
The key tension to watch into that date: whether Rady's continued accumulation — buying every dip below $23 — begins to establish a floor in a stock that has lost ground after each of its last two earnings releases.
See the live data behind this article on ORTEX.
Open AAT on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
